1 / 33

The role of Process Control in Process Analytical Technology (PAT)

The role of Process Control in Process Analytical Technology (PAT). Arne Koggersbøl, NNE A/S, Denmark APACT 05 Birmingham, April 20-22. About NNE. Consultancy and engineering to the international pharmaceutical and biotechnological industry

dakota
Download Presentation

The role of Process Control in Process Analytical Technology (PAT)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The role of Process Controlin Process Analytical Technology (PAT) Arne Koggersbøl, NNE A/S, Denmark APACT 05 Birmingham, April 20-22

  2. About NNE • Consultancy and engineering to the international pharmaceutical and biotechnological industry • More than 70 customers round the world.Brazil, China, Denmark, France, Ireland, Japan, Sweden, Switzerland, USA • Project volumes: 3,000 – 300,000,000 € • PAT / Process Analysis and Control. • Conceptual designs and strategy consultancy. • Construction projects: Building, mechanical, automation, etc. • Fast track projects.14½ month from green-field to insulin purification plant. • Worlds largest insulin production plant (in 2003). www.nne.biz

  3. Why is PAT interesting? • North American pharmaceutical market (in 2003) 200 Billion € 49% of the world market • Heavily regulated by Food and Drug Administration (FDA) • And … www.nne.biz

  4. PAT is FDA’s offerto ease the regulatory burden Heavyregulatoryburden PAT www.nne.biz

  5. What burden? • Todays definition of a drug product: • procedure • equipment • conditions • certain end-product properties • Burden: Provide evidence! (validation) • Validation is establishment of documented evidence that the process to a high degree of certainty will perform consistently according to specifications. www.nne.biz

  6. Effect of burden Pharmaceutical industry is behind • Innovation is slow Not World Class performing like other industries • flight • electronics • food • chemicals • petrochemicals www.nne.biz

  7. Effect of burden • Industry Perspective: • Utilisation levels - 15% or less • Scrap and rework - plan for 5-10% • Time to effectiveness - takes years • Hesitant to innovate • Public Health Perspective • Increasing trend toward manufacturing-related problems • Recalls: 176 in 1998354 in 2002 Dr. Janet Woodcock,FDA Science Board www.nne.biz

  8. What’s PAT • Future definition of a drug product: • critical quality attributes • Prerequisites: • risc based approach • measure or analyse • active control • design quality control into process • Mantra: • Process understanding • Design, analysis and control • System www.nne.biz

  9. PAT versus PAC • Is PAT what we’ve been doing for years and called PAC? • PAT is more: • PAT is a new approach to process validationin relation to FDA and to EMEA • PAT is not necessarily closed-loop control • Strong focus on final product quality • Process understanding is essential • The methods of PAC may be seen as PAT-tools: • Analysis tools • Control tools • A PAC application may be developed into a PAT application. www.nne.biz

  10. PAT Typical tasks of the control engineer Process understanding Design Analysis Control Model Diff. equations Data driven XX X XX Controllability study Equipment modifica. X X X Control strategy development X X Prediction and observers X Signal processing X - a PAT-interpretation Process Control www.nne.biz

  11. SPC Process Control - in a PAT framework Engineering Process Control • subject to continuous improvement • focus on final product quality Product quality • inversely proportional to variance • subject to statistical analysis EPC Process Identifycause If out of control EPC = Engineering Process Control SPC = Statistical Process Control www.nne.biz

  12. Process www.nne.biz

  13. OutputConcernInput Process review Sterile andnutritiousThermal degradation- Particle free product solution.High YieldFoulingInput as clear as possible Stable biomass and productconcentrationMetabolismSterile and nutritious feed Clear supernatantThrough-putStable inlet concentration of dry-matter www.nne.biz

  14. Step 1: 5 filters in parallel Feed Step 2: 2 filters in parallel Water Product Waste Micro filtration • Step 1: • Flow control on permeate and retentateto obtain required separation • Step 2: • Balancing retentate flows to avoid fouling run-away • Control permeate flows to obtain required yield • Control up-stream pressure (feed pressure) www.nne.biz

  15. Micro filtrationSolutions Pressure-flow model for valves and filters Adaptive:K-factors are estimated continuously Anti-fouling control: Yield control: Pressure control indirectly byperturbing the flow control algorithm: Step 2:2 filters in parallel Feed Waste Product www.nne.biz

  16. Micro filtrationBenefits Process understanding: Valve and filter models. • Valve and filter characteristics estimated continuously. • Monitoring changes in characteristics used for maintenance purposes. • Adaptive control of pressure and flowrobust towards: • Changing valve characteristics. • Filter fouling. • Change of filter characteristics.Case: Unproblematic introduction of new filter type. www.nne.biz

  17. Micro filtrationPAT perspective • Flows are critical (pressures are important) • These are measured • Process understanding • Basis for the control solution • Enhanced while producing the solution • Analysis on-line based on process model • All above is used for control • Consistent production based on flow requirements • Product not defined in terms of e.g. specific micro filter material • Future • Detection of leakage through membranes • Optimisation of yield using analyser www.nne.biz

  18. Centrifugation • Objective: Clear supernatant • Concern: Optimise through-put • Optimum is feed-flow dependent www.nne.biz

  19. CentrifugationSolution • Continuous optimisation of feed/flocculant ratio using • pertubation of the ratio signal. • signal processing, noise handling. www.nne.biz

  20. CentrifugationBenefits Feed flow Low sludge High sludge Time www.nne.biz

  21. CentrifugationPAT perspective • Clearness is critical • This is measured • Process understanding • is the basis for the solution • Analysis on-line based on pertubations • All above is used for control • Consistent production based on clearness requirement • Product not defined in terms of e.g. use of a specific centrifuge with a specific flocculant and a specific feed/flocculant ratio. www.nne.biz

  22. Fermentation • Objective: Stable biomass and product concentration • Concern: Optimise production avoid metabolism change avoid metabolism overflow. • Complex medium • Carbon • Protein • Salts, vitamins, trace metals, etc. www.nne.biz

  23. FermentationSolutions • Change from 1 to 2 feed streams • Carbon hydrate medium (Speed)Feedback control • Complex medium (Product/impurity) • On-line off-gas analysis used to determinestate of metabolism (respiration/fermentation). www.nne.biz

  24. FermentationBenefits • Improved monitoring of metabolism • helps keep process on a high-yield metabolic path • Metabolism overflow avoided • controlling dissolved oxygen using carbon hydrate flowrate • Begin using standardised media www.nne.biz

  25. FermentationPAT-perspective • State of metabolism is critical • This is analysed and controlled for profit, not quality • Process understanding enhanced for profit, not quality • Carbon hydrate source may not be indifferent to cells • Complex feed composition is essential Typically not used for feed-back quality control • Product is defined in terms of • physical conditions (temperature, pressure, pH, aeration, agitation and time) , and • geometry of certain equipment.The link to product quality is usually not well understood. www.nne.biz

  26. FermentationFuture PAT • Enhancement of process understanding for product quality control • Further decoupling of media effects • Tighter metabolism control based on analysis of metabolites • Impurity monitoring and control • Important for downstream processing • Infection monitoring. www.nne.biz

  27. Continuous sterilisation • Objective: Sterile and nutritious product. • Concern: Thermal degradation of nutrientsHow to handle disturbances diminishing lethality (F0) www.nne.biz

  28. Continuous sterilisation • Individual control of flow and temperature to obtain F0-target. • F0-target set high to take into account simultaneous disturbances in temperature and flow. • This results in undesired thermal degradation of nutrients. www.nne.biz

  29. Continuous sterilisationSolution • F0-estimator based on mathematical model • enables tight control • F0-target can be set close to the minimum www.nne.biz

  30. Continuous sterilisationBenefits • Improved quality of product • Less degradation of nutrients • More confidence in product quality • Monitoring has been enabled. www.nne.biz

  31. Continuous sterilisationPAT-perspective • Sterility is critical ……………………… Not measured • Lethality is not critical ……………… Analysed and controlled • Thermal degradation is critical … Not measured • Probably consistent production based on lethality requirement • Consistent lethality  consistent degradation ? • Product is defined in terms of fixed conditions:Exposing the medium to a certain lethal effect regardless of initial amount of life. • Future PAT • Measure live biomass at points in the process • Measure non-degraded nutrients www.nne.biz

  32. Points • PAT is a potential revolution for the pharmaceutical industry • Be alert (there are jobs here) • Process control engineers have significant roles to play • Similar mindsets • PAT-solutions are likely to start as PAC-solutions • When doing PAC in pharmaceutical production, think: • “process understanding” • “design, analysis & control” • “continuous improvement” • “risk based” www.nne.biz

  33. Further information Arne Koggersbøl akog@nne.dk +45 3079 7579 www.nne.biz

More Related